Additionally, acquired periostin in breast cancer promotes tumor angiogenesis by upregulating the expression of endothelial growth factor receptor 2 (18) and use of a periostin antibody significantly inhibits tumor growth and angiogenesis in vivo (27). Here, POSTN is linked to breast carcinoma.